India's drugs regulator gives nod to phase-3 clinical trial of Covid vaccine Covovax

Covovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing authorisation. It was granted emergency-use listing by the World Health Organization (WHO) in December 2020. In August 2020, US-based vaccine-maker Novavax Inc. had announced a licence agreement with the SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low-and-middle-income countries and in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/jsnvICa
via IFTTT